Standard Chemical & Pharmaceutical Co. Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 1,509 million compared to TWD 1,481.06 million a year ago. Net income was TWD 238.31 million compared to TWD 228.54 million a year ago. Basic earnings per share from continuing operations was TWD 1.33 compared to TWD 1.28 a year ago. Diluted earnings per share from continuing operations was TWD 1.33 compared to TWD 1.28 a year ago.
For the six months, sales was TWD 3,002.03 million compared to TWD 2,718.23 million a year ago. Net income was TWD 449.29 million compared to TWD 401.91 million a year ago. Basic earnings per share from continuing operations was TWD 2.51 compared to TWD 2.25 a year ago. Diluted earnings per share from continuing operations was TWD 2.51 compared to TWD 2.25 a year ago.